How to Segment AI-Using Consumers: The Harris Poll AI Atlas, and What It Means for Healthcare
By Jane Sarasohn-Kahn on 6 August 2026 in Affordability, AI, AI and health, Artificial intelligence, Augmented intelligence, Behavior change, Behavioral health, Big Tech, Bio/life sciences, Bioethics, Business and health, Chatbots and health, ChatGPT, Computers and health, Connected health, Consumer electronics, Consumer experience, Consumer-directed health, Demographics and health, Design and health, Digital health, Digital therapeutics, Digital transformation, DTC health, Education and health, Empathy, Financial health, Financial wellness, Future of health care, Health access, Health apps, Health at home, Health care industry, Health Consumers, Health ecosystem, Health education, Health engagement, Health literacy, Health marketing, Health media, Health policy, Health privacy, Healthcare access, Large language models LLMs, Medical innovation, Omnichannel healthcare, Patient engagement, Patient experience, Popular culture and health, Public health, Retail health, Risk management, Robots, Robots and health, Security and health data, Self-care, Shopping and health, Social networks and health, Social responsibility, Transparency, Trust, User experience UX, Virtual health, Wellbeing

AI adoption is scaling faster than trust, where trust is tied to concerns about data privacy, transparency, and control in the U.S., Canada, and the UK. Welcome to the AI Atlas, what The Harris Poll calls “A living map of how people relate to AI and how those relationships evolve.” I consumed the Atlas with my lens on healthcare and self-care firmly in context, and in the Hot Points below, distill some thoughts on Harris’s fascinating market segmentation of AI/consumers. To construct the Atlas, The Harris Poll conducted a survey online in





I'm gratified to be named on
I’m celebrating America’s 250th birthday both patriotically and professionally, honored that the NLM included my 2010 paper, “How Smartphones Are Changing Healthcare for Consumers and Patients” as one of 250 items curated for the digital archive of 250 Years of American Medicine.
I'm grateful to be part of the Duke Corporate Education faculty, sharing perspectives on the future of health care with health and life science companies. Once again, I'll be brainstorming the future of health care with a cohort of executives working in a global health care enterprise.